Abstract: New methods for purifying Hepatitis A virus (HAV) are to commercial scale-up and manufacture of specific HAV vaccines, including formalin-inactivated HAV and attenuated HAV.
Type:
Grant
Filed:
October 28, 1992
Date of Patent:
May 28, 1996
Assignee:
Merck & Co., Inc.
Inventors:
John A. Lewis, Marcy E. Armstrong, Emilio A. Emini